<DOC>
	<DOCNO>NCT00494299</DOCNO>
	<brief_summary>Clinical trial BAY43-9006 patient hepatocellular carcinoma .</brief_summary>
	<brief_title>Phase III Study BAY43-9006 Patients With Advanced Hepatocellular Carcinoma ( HCC ) Treated After Transcatheter Arterial Chemoembolization ( TACE )</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Sorafenib</mesh_term>
	<mesh_term>Niacinamide</mesh_term>
	<criteria>Male female Aged 18 Advanced hepatocellular carcinoma History prior systemic chemotherapy Failure vital organ</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>HCC</keyword>
	<keyword>Cancer</keyword>
	<keyword>Liver Cancer</keyword>
	<keyword>TACE</keyword>
</DOC>